Literature DB >> 18660472

Incidence of epilepsies and epileptic syndromes among children in Navarre, Spain: 2002 through 2005.

Teodoro Durá-Travé1, Maria Eugenia Yoldi-Petri, Fidel Gallinas-Victoriano.   

Abstract

All incident cases of children living in Navarre, Spain, younger than 15 years of age with newly diagnosed epilepsy (2002-2005) were registered in a prospective study, with epidemiologic and clinical data and complementary study results collected. Based on International League Against Epilepsy criteria, 191 patients were diagnosed as having epilepsy. The overall incidence rate is 62.6 cases per 100 000, with the highest incidence (95.3 cases per 100 000) during the first year of life. Fifty-five percent of patients have focal epilepsies, 42.9% generalized epilepsies, and 2.1% undetermined epilepsies. Among infants, West syndrome (45.5%), epilepsies associated with specific syndromes (27.3%), and focal symptomatic epilepsies (13.6%) are the most prevalent syndromes. In early childhood, the main syndromes are focal symptomatic (22.7%) and cryptogenic (21.2%) epilepsies and Doose syndrome (13.6%). Among school-aged children, focal benign epilepsies (27.8%) and cryptogenic and absence epilepsies (18.5% for both) are the most prevalent, with focal cryptogenic epilepsies (26.5%) and benign epilepsies (18.4%) most prevalent among adolescents.

Entities:  

Mesh:

Year:  2008        PMID: 18660472     DOI: 10.1177/0883073808314898

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  8 in total

Review 1.  Preoperative evaluation and surgical decision-making in pediatric epilepsy surgery.

Authors:  Katrina Ducis; Jian Guan; Michael Karsy; Robert J Bollo
Journal:  Transl Pediatr       Date:  2016-07

Review 2.  Infantile Spasms-Have We Made Progress?

Authors:  Sarah Aminoff Kelley; Kelly G Knupp
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-19       Impact factor: 5.081

3.  Management practices for West syndrome in South Asia: A survey study and meta-analysis.

Authors:  Priyanka Madaan; Prem Chand; Kyaw Linn; Jithangi Wanigasinghe; Mimi Lhamu Mynak; Prakash Poudel; Raili Riikonen; Amit Kumar; Pooja Dhir; Sandeep Negi; Jitendra Kumar Sahu
Journal:  Epilepsia Open       Date:  2020-08-11

Review 4.  The challenges and innovations for therapy in children with epilepsy.

Authors:  Jo M Wilmshurst; Anne T Berg; Lieven Lagae; Charles R Newton; J Helen Cross
Journal:  Nat Rev Neurol       Date:  2014-04-08       Impact factor: 42.937

5.  Cognitive disorders in childhood epilepsy: a comparative longitudinal study using administrative healthcare data.

Authors:  Anna-Lisa Sorg; Rüdiger von Kries; Ingo Borggraefe
Journal:  J Neurol       Date:  2022-02-15       Impact factor: 6.682

6.  Adult Prevalence of Epilepsy in Spain: EPIBERIA, a Population-Based Study.

Authors:  Pedro J Serrano-Castro; Jose Angel Mauri-Llerda; Francisco José Hernández-Ramos; Juan Carlos Sánchez-Alvarez; Beatriz Parejo-Carbonell; Pablo Quiroga-Subirana; Fernando Vázquez-Gutierrez; Sonia Santos-Lasaosa; Carolina Mendez-Lucena; Luis Redondo-Verge; Carlos Tejero-Juste; Clara Morandeira-Rivas; Jerónimo Sancho-Rieger; Jorge Matías-Guiu
Journal:  ScientificWorldJournal       Date:  2015-12-10

7.  Management of Infantile Spasms During the COVID-19 Pandemic.

Authors:  Zachary M Grinspan; John R Mytinger; Fiona M Baumer; Michael A Ciliberto; Bruce H Cohen; Dennis J Dlugos; Chellamani Harini; Shaun A Hussain; Sucheta M Joshi; Cynthia G Keator; Kelly G Knupp; Patricia E McGoldrick; Katherine C Nickels; Jun T Park; Archana Pasupuleti; Anup D Patel; Asim M Shahid; Renee A Shellhaas; Daniel W Shrey; Rani K Singh; Steven M Wolf; Elissa G Yozawitz; Christopher J Yuskaitis; Jeff L Waugh; Phillip L Pearl
Journal:  J Child Neurol       Date:  2020-06-23       Impact factor: 1.987

8.  Latitudinal differences on the global epidemiology of infantile spasms: systematic review and meta-analysis.

Authors:  Jason L Jia; Shiyi Chen; Vishalini Sivarajah; Derek Stephens; Miguel A Cortez
Journal:  Orphanet J Rare Dis       Date:  2018-11-29       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.